PubRank

Taesoo Kim

Author PubWeight™ 27.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2006 3.78
2 TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med 2006 2.44
3 The specificity and topology of chromatin interaction pathways in yeast. Mol Cell 2011 2.04
4 OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest 2011 1.38
5 The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem 2008 1.29
6 Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metab 2013 1.09
7 A key role for Chd1 in histone H3 dynamics at the 3' ends of long genes in yeast. PLoS Genet 2012 1.02
8 Free radical theory of aging: implications in male infertility. Urology 2009 1.01
9 The fission yeast Jmj2 reverses histone H3 Lysine 4 trimethylation. J Biol Chem 2007 1.01
10 NHE10, an osteoclast-specific member of the Na+/H+ exchanger family, regulates osteoclast differentiation and survival [corrected]. Biochem Biophys Res Commun 2008 1.00
11 Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J Immunol 2008 0.95
12 A Novel Herbal Medicine KIOM-MA Exerts an Anti-Inflammatory Effect in LPS-Stimulated RAW 264.7 Macrophage Cells. Evid Based Complement Alternat Med 2012 0.91
13 Aristolochia manshuriensis Kom inhibits adipocyte differentiation by regulation of ERK1/2 and Akt pathway. PLoS One 2012 0.87
14 Inhibitory Effects of Hwangryunhaedok-Tang in 3T3-L1 Adipogenesis by Regulation of Raf/MEK1/ERK1/2 Pathway and PDK1/Akt Phosphorylation. Evid Based Complement Alternat Med 2013 0.84
15 The role of nacreous factors in preventing osteoporotic bone loss through both osteoblast activation and osteoclast inactivation. Biomaterials 2012 0.83
16 Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-κB activation and MMP-9 expression. Oncol Rep 2013 0.82
17 Lactobacillus fermentation enhances the inhibitory effect of Hwangryun-haedok-tang in an ovariectomy-induced bone loss. BMC Complement Altern Med 2013 0.80
18 Hwangryun-Haedok-Tang Fermented with Lactobacillus casei Suppresses Ovariectomy-Induced Bone Loss. Evid Based Complement Alternat Med 2012 0.80
19 Food- and gender-dependent pharmacokinetics of paeoniflorin after oral administration with Samul-tang in rats. J Ethnopharmacol 2012 0.80
20 Antithrombotic and antiplatelet activities of Soshiho-tang extract. BMC Complement Altern Med 2013 0.80
21 In Vitro and In Vivo Genotoxicity Assessment of Aristolochia manshuriensis Kom. Evid Based Complement Alternat Med 2012 0.78
22 Ethanol extract of Atractylodes macrocephala protects bone loss by inhibiting osteoclast differentiation. Molecules 2013 0.77
23 Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption. BMC Complement Altern Med 2013 0.77
24 Water Extract of Dryopteris crassirhizoma Attenuates Bone Loss by Suppressing Osteoclast Differentiation and Function. Evid Based Complement Alternat Med 2013 0.75
25 Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss. BMC Complement Altern Med 2014 0.75
26 Polyelectrolyte multilayer-assisted fabrication of non-periodic silicon nanocolumn substrates for cellular interface applications. Nanoscale 2015 0.75
27 Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression. Am J Chin Med 2015 0.75